FDA Submits Collection of Information for OMB Review Under Paperwork Reduction Act

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, as required by the Paperwork Reduction Act of 1995, in response to a comment request regarding foreign clinical studies not conducted under an Investigational New Drug Application